TSX/AVCN (TSX/AVCN)

Toronto Stock Exchange: TSX/AVCN · CAD

CA$0.11

+0.00 (0.0%)· Recorded snapshot

Market cap	14.5M
Revenue (ttm)	25.3M
Net income (ttm)	-3.7M
EPS (ttm)	-CA$0.03
Shares out	137.7M
Volume	0
Beta	0.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 25.3M
Net income (ttm): -3.7M
EPS (ttm): -CA$0.03
Market cap: 14.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-30

P25 n/aP50 n/aP75 n/a

ROIC-17.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/AVCN indicators

Market & fundamental data

Available fields

176

Groups with data

Currency

CAD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-13
Employees	112
Employees change	25
Employees growth	28.74%
Enterprise value	CAD 23.8M
Exchange	Toronto Stock Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2016
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA05368K1003
Last earnings date	2025-11-11
Last refreshed	2026-10-29
Market cap	CAD 14.5M
Next earnings date	2026-11-13
Price	CAD 0.11
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	tsx/AVCN
Website	https://www.avicanna.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-29.65%
EV/Sales	0.94x
FCF / EV yield	-13.39%
FCF yield	-22.07%
Industry forward P/E	34.4x
P/B ratio	1.03x
P/S ratio	0.57x
Price / tangible book value	3.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-14.02%
EBITDA margin	-12.28%
Gross margin	54.59%
Operating margin	-14.02%
Pretax margin	-14.75%
Profit margin	-14.75%
Profit per employee	CAD -33,340
Revenue per employee	CAD 226,021
ROA	-9.95%
ROA (5Y)	-22.37%
ROCE	-24.48%
ROE	-30.04%
ROE (5Y)	-135.28%
ROIC	-17.69%
SBC / revenue	5.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	5
Gross profit growth	5.9%
Gross profit growth (Q)	2.05%
Gross profit growth 3Y	173.17%
Net income growth years	5
Revenue growth	-0.23%
Revenue growth (Q)	-8.45%
Revenue growth (QoQ)	-15.61%
Revenue growth 3Y	58.21%
Revenue growth 5Y	72.39%
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -206,876
Depreciation and amortization	CAD 440,858
EBIT	CAD -3.5M
EBITDA	CAD -3.1M
EPS	CAD -0.03
FCF per share	CAD -0.02
Financing cash flow	CAD 3M
Free cash flow	CAD -3.2M
Free cash flow minus SBC	CAD -4.5M
Gross profit	CAD 13.8M
Investing cash flow	CAD -207,877
Net borrowing	CAD -199,016
Net cash flow	CAD -7,220
Net income	CAD -3.7M
Operating cash flow minus SBC	CAD -4.3M
Operating income	CAD -3.5M
Revenue	CAD 25.3M
Stock-based compensation	CAD 1.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-4.15
Book value per share	CAD 0.03
Debt / equity	0.01
Goodwill	CAD 334,000
Interest coverage	-59.15
Long-term assets	CAD 14.8M
Long-term liabilities	CAD 488,519
Net cash (debt)	CAD 30,854
Net cash / market cap	0.21%
Net cash growth	-81.91%
Net debt / equity	-0
Piotroski F-Score	3
Property, plant and equipment	CAD 13.9M
Shareholders' equity	CAD 14M
Tangible book value	CAD 3.8M
Tangible book value per share	CAD 0.03
Total assets	CAD 24.1M
Total cash	CAD 200,418
Total debt	CAD 169,564
Total liabilities	CAD 10.1M
WACC	6.41%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.14
Current assets	CAD 9.4M
Current liabilities	CAD 9.6M
Current ratio	0.97
Inventory turnover	2.67
Net working capital	CAD -306,363
Quick ratio	0.45
Working capital	CAD -275,509
Working capital turnover	-38.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-9.7%
Shareholder yield	-9.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.13
1D price change	0%
1W price change	5%
1W total return	5%
1Y price change	-59.62%
1Y return CAGR	-59.64%
1Y total return	-59.62%
20-day SMA	CAD 0.10
200-day SMA	CAD 0.15
3M price change	-19.23%
3M total return	-19.23%
3Y price change	-74.07%
3Y return CAGR	-36.23%
3Y total return	-74.07%
50-day SMA	CAD 0.12
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.28
52-week high date	2025-11-19
52-week low	CAD 0.10
52-week low date	2026-10-19
5Y price change	-87.5%
5Y return CAGR	-34.03%
5Y total return	-87.5%
6M price change	-27.59%
6M total return	-27.59%
All-time high	CAD 7.40
All-time high date	2019-07-18
All-time low	CAD 0.10
All-time low date	2026-07-08
Average true range (ATR)	CAD 0.01
Average volume	81.2K
Beta (1Y)	0.96
Beta (2Y)	1.45
Beta (5Y)	0.35
Change from 52-week high	-62.5%
Change from 52-week low	10.53%
Change from all-time high	-98.58%
Change from all-time low	10.53%
Monthly RSI	32.52
Previous close	CAD 0.11
Price vs 150-day SMA	-18.67%
Price vs 20-day SMA	0.67%
Price vs 200-day SMA	-28.38%
Price vs 50-day SMA	-8.93%
Relative volume	0.64
RSI	48.1
Sharpe ratio	-0.96
Sharpe ratio (3Y)	-0.17
Sharpe ratio (5Y)	-0.04
Sortino ratio	-1.24
Sortino ratio (3Y)	-0.18
Sortino ratio (5Y)	0
Volume	0
Weekly RSI	36.94
YTD price change	-53.33%
YTD total return	-53.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	120.6M
Shares change (QoQ)	6.01%
Shares change (YoY)	9.7%
Shares held by insiders	10.83%
Shares held by institutions	9.38%
Shares outstanding	137.7M
Short % of float	0.13%
Short % of shares	0.1%

Deeper analysis on TSX/AVCN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/AVCN report

Is a complete TSX/AVCN research report available?

No complete published report is available for tsx/AVCN (TSX/AVCN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/AVCN (TSX/AVCN)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/AVCN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/AVCN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/AVCN

Frequently asked questions